Cronos Group (NASDAQ:CRON – Get Free Report) and Silo Pharma (NASDAQ:SILO – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.
Profitability
This table compares Cronos Group and Silo Pharma’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cronos Group | 39.08% | 4.85% | 4.62% |
| Silo Pharma | -6,726.39% | -81.75% | -66.35% |
Volatility & Risk
Cronos Group has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Silo Pharma has a beta of 0.76, suggesting that its share price is 24% less volatile than the S&P 500.
Valuation and Earnings
This table compares Cronos Group and Silo Pharma”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cronos Group | $146.59 million | 8.30 | -$9.45 million | $0.20 | 16.50 |
| Silo Pharma | $70,000.00 | 27.94 | -$4.23 million | ($4.36) | -0.28 |
Silo Pharma has lower revenue, but higher earnings than Cronos Group. Silo Pharma is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and recommmendations for Cronos Group and Silo Pharma, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cronos Group | 0 | 1 | 3 | 1 | 3.00 |
| Silo Pharma | 1 | 0 | 0 | 0 | 1.00 |
Cronos Group currently has a consensus price target of $2.30, suggesting a potential downside of 30.30%. Given Cronos Group’s stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Silo Pharma.
Institutional & Insider Ownership
8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Comparatively, 3.6% of Silo Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Cronos Group beats Silo Pharma on 13 of the 15 factors compared between the two stocks.
About Cronos Group
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
About Silo Pharma
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company’s two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company’s research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.
